nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—HTR3A—enteric nervous system—Crohn's disease	0.0448	0.175	CbGeAlD
Quetiapine—HTR3A—myenteric nerve plexus—Crohn's disease	0.034	0.133	CbGeAlD
Quetiapine—HTR7—enteric nervous system—Crohn's disease	0.029	0.113	CbGeAlD
Quetiapine—HTR7—myenteric nerve plexus—Crohn's disease	0.022	0.0858	CbGeAlD
Quetiapine—CHRM3—muscle of abdomen—Crohn's disease	0.0193	0.0754	CbGeAlD
Quetiapine—HTR2A—enteric nervous system—Crohn's disease	0.0181	0.0706	CbGeAlD
Quetiapine—HTR2A—myenteric nerve plexus—Crohn's disease	0.0137	0.0535	CbGeAlD
Quetiapine—CHRM5—epithelium—Crohn's disease	0.00411	0.016	CbGeAlD
Quetiapine—CHRM5—skin of body—Crohn's disease	0.00391	0.0153	CbGeAlD
Quetiapine—HTR7—mouth—Crohn's disease	0.00376	0.0147	CbGeAlD
Quetiapine—ADRA1D—epithelium—Crohn's disease	0.00368	0.0143	CbGeAlD
Quetiapine—DRD5—lymphoid tissue—Crohn's disease	0.00353	0.0138	CbGeAlD
Quetiapine—H1F0—smooth muscle tissue—Crohn's disease	0.00342	0.0133	CbGeAlD
Quetiapine—H1F0—skin of body—Crohn's disease	0.00337	0.0132	CbGeAlD
Quetiapine—H1F0—mammalian vulva—Crohn's disease	0.00308	0.012	CbGeAlD
Quetiapine—H1F0—lymphoid tissue—Crohn's disease	0.00273	0.0107	CbGeAlD
Quetiapine—H1F0—digestive system—Crohn's disease	0.0027	0.0105	CbGeAlD
Quetiapine—HTR3A—digestive system—Crohn's disease	0.00257	0.01	CbGeAlD
Quetiapine—CHRM3—smooth muscle tissue—Crohn's disease	0.00222	0.00864	CbGeAlD
Quetiapine—HTR7—epithelium—Crohn's disease	0.00219	0.00854	CbGeAlD
Quetiapine—ADRA1A—epithelium—Crohn's disease	0.00211	0.00824	CbGeAlD
Quetiapine—HTR7—smooth muscle tissue—Crohn's disease	0.00211	0.00823	CbGeAlD
Quetiapine—CHRM3—digestive system—Crohn's disease	0.00175	0.00683	CbGeAlD
Quetiapine—ADRA2C—mammalian vulva—Crohn's disease	0.00174	0.00681	CbGeAlD
Quetiapine—HTR7—digestive system—Crohn's disease	0.00166	0.0065	CbGeAlD
Quetiapine—HRH1—epithelium—Crohn's disease	0.00163	0.00638	CbGeAlD
Quetiapine—CYP2C19—digestive system—Crohn's disease	0.00163	0.00634	CbGeAlD
Quetiapine—ADRA1A—lymphoid tissue—Crohn's disease	0.00163	0.00634	CbGeAlD
Quetiapine—HRH1—smooth muscle tissue—Crohn's disease	0.00157	0.00614	CbGeAlD
Quetiapine—H1F0—lymph node—Crohn's disease	0.00154	0.00601	CbGeAlD
Quetiapine—HRH1—mammalian vulva—Crohn's disease	0.00142	0.00553	CbGeAlD
Quetiapine—ADRA2A—mammalian vulva—Crohn's disease	0.00139	0.00543	CbGeAlD
Quetiapine—HTR2A—epithelium—Crohn's disease	0.00136	0.00533	CbGeAlD
Quetiapine—HTR2A—smooth muscle tissue—Crohn's disease	0.00131	0.00513	CbGeAlD
Quetiapine—CYP3A5—digestive system—Crohn's disease	0.00128	0.005	CbGeAlD
Quetiapine—Acne—Prednisone—Crohn's disease	0.00126	0.00292	CcSEcCtD
Quetiapine—Influenza—Mesalazine—Crohn's disease	0.00125	0.00291	CcSEcCtD
Quetiapine—Dysphagia—Mesalazine—Crohn's disease	0.00125	0.00291	CcSEcCtD
Quetiapine—Asthma—Mesalazine—Crohn's disease	0.00125	0.00291	CcSEcCtD
Quetiapine—Anorexia—Mercaptopurine—Crohn's disease	0.00125	0.00291	CcSEcCtD
Quetiapine—HRH1—digestive system—Crohn's disease	0.00124	0.00485	CbGeAlD
Quetiapine—Eosinophilia—Mesalazine—Crohn's disease	0.00124	0.00288	CcSEcCtD
Quetiapine—Pneumonia—Azathioprine—Crohn's disease	0.00123	0.00287	CcSEcCtD
Quetiapine—Delirium—Prednisone—Crohn's disease	0.00123	0.00286	CcSEcCtD
Quetiapine—Pancreatitis—Mesalazine—Crohn's disease	0.00123	0.00286	CcSEcCtD
Quetiapine—Infestation NOS—Azathioprine—Crohn's disease	0.00123	0.00285	CcSEcCtD
Quetiapine—Infestation—Azathioprine—Crohn's disease	0.00123	0.00285	CcSEcCtD
Quetiapine—Angina pectoris—Mesalazine—Crohn's disease	0.00122	0.00284	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.00122	0.00283	CcSEcCtD
Quetiapine—Contusion—Prednisone—Crohn's disease	0.00121	0.00282	CcSEcCtD
Quetiapine—Bronchitis—Mesalazine—Crohn's disease	0.00121	0.0028	CcSEcCtD
Quetiapine—Amenorrhoea—Prednisone—Crohn's disease	0.0012	0.0028	CcSEcCtD
Quetiapine—Abdominal discomfort—Mesalazine—Crohn's disease	0.0012	0.00279	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0012	0.00278	CcSEcCtD
Quetiapine—Neutropenia—Mesalazine—Crohn's disease	0.00117	0.00272	CcSEcCtD
Quetiapine—Dysuria—Mesalazine—Crohn's disease	0.00117	0.00272	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00117	0.00271	CcSEcCtD
Quetiapine—Arthropathy—Prednisone—Crohn's disease	0.00116	0.0027	CcSEcCtD
Quetiapine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00116	0.0027	CcSEcCtD
Quetiapine—Pollakiuria—Mesalazine—Crohn's disease	0.00116	0.00269	CcSEcCtD
Quetiapine—Agranulocytosis—Azathioprine—Crohn's disease	0.00115	0.00266	CcSEcCtD
Quetiapine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00114	0.00266	CcSEcCtD
Quetiapine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00114	0.00265	CcSEcCtD
Quetiapine—Weight increased—Mesalazine—Crohn's disease	0.00114	0.00265	CcSEcCtD
Quetiapine—Weight decreased—Mesalazine—Crohn's disease	0.00113	0.00264	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00113	0.00263	CcSEcCtD
Quetiapine—Leukocytosis—Prednisone—Crohn's disease	0.00113	0.00261	CcSEcCtD
Quetiapine—Pneumonia—Mesalazine—Crohn's disease	0.00112	0.00261	CcSEcCtD
Quetiapine—Infestation—Mesalazine—Crohn's disease	0.00112	0.0026	CcSEcCtD
Quetiapine—Infestation NOS—Mesalazine—Crohn's disease	0.00112	0.0026	CcSEcCtD
Quetiapine—Depression—Mesalazine—Crohn's disease	0.00111	0.00259	CcSEcCtD
Quetiapine—Cataract—Prednisone—Crohn's disease	0.00111	0.00258	CcSEcCtD
Quetiapine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00111	0.00257	CcSEcCtD
Quetiapine—Haemoglobin—Azathioprine—Crohn's disease	0.00111	0.00257	CcSEcCtD
Quetiapine—Haemorrhage—Azathioprine—Crohn's disease	0.0011	0.00256	CcSEcCtD
Quetiapine—Stomatitis—Mesalazine—Crohn's disease	0.00109	0.00253	CcSEcCtD
Quetiapine—Jaundice—Mesalazine—Crohn's disease	0.00109	0.00253	CcSEcCtD
Quetiapine—Conjunctivitis—Mesalazine—Crohn's disease	0.00109	0.00252	CcSEcCtD
Quetiapine—Urinary tract infection—Mesalazine—Crohn's disease	0.00109	0.00252	CcSEcCtD
Quetiapine—Sweating—Mesalazine—Crohn's disease	0.00107	0.00249	CcSEcCtD
Quetiapine—Hiccups—Prednisone—Crohn's disease	0.00106	0.00246	CcSEcCtD
Quetiapine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00106	0.00246	CcSEcCtD
Quetiapine—Epistaxis—Mesalazine—Crohn's disease	0.00105	0.00245	CcSEcCtD
Quetiapine—Sinusitis—Mesalazine—Crohn's disease	0.00105	0.00244	CcSEcCtD
Quetiapine—Agranulocytosis—Mesalazine—Crohn's disease	0.00104	0.00242	CcSEcCtD
Quetiapine—Erythema multiforme—Azathioprine—Crohn's disease	0.00104	0.00242	CcSEcCtD
Quetiapine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00104	0.00241	CcSEcCtD
Quetiapine—HTR2A—digestive system—Crohn's disease	0.00104	0.00405	CbGeAlD
Quetiapine—Haemoglobin—Mesalazine—Crohn's disease	0.00101	0.00234	CcSEcCtD
Quetiapine—Rhinitis—Mesalazine—Crohn's disease	0.00101	0.00234	CcSEcCtD
Quetiapine—Haemorrhage—Mesalazine—Crohn's disease	0.001	0.00233	CcSEcCtD
Quetiapine—Hepatitis—Mesalazine—Crohn's disease	0.001	0.00233	CcSEcCtD
Quetiapine—Pharyngitis—Mesalazine—Crohn's disease	0.000996	0.00231	CcSEcCtD
Quetiapine—Immune system disorder—Azathioprine—Crohn's disease	0.000995	0.00231	CcSEcCtD
Quetiapine—Mediastinal disorder—Azathioprine—Crohn's disease	0.000993	0.00231	CcSEcCtD
Quetiapine—Urinary tract disorder—Mesalazine—Crohn's disease	0.000991	0.0023	CcSEcCtD
Quetiapine—Oedema peripheral—Mesalazine—Crohn's disease	0.000989	0.0023	CcSEcCtD
Quetiapine—Chills—Azathioprine—Crohn's disease	0.000989	0.0023	CcSEcCtD
Quetiapine—Connective tissue disorder—Mesalazine—Crohn's disease	0.000986	0.00229	CcSEcCtD
Quetiapine—Urethral disorder—Mesalazine—Crohn's disease	0.000984	0.00229	CcSEcCtD
Quetiapine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000968	0.00225	CcSEcCtD
Quetiapine—CYP3A4—digestive system—Crohn's disease	0.000961	0.00375	CbGeAlD
Quetiapine—Ecchymosis—Prednisone—Crohn's disease	0.000956	0.00222	CcSEcCtD
Quetiapine—Erythema multiforme—Mesalazine—Crohn's disease	0.000949	0.0022	CcSEcCtD
Quetiapine—CYP2D6—digestive system—Crohn's disease	0.000946	0.00369	CbGeAlD
Quetiapine—Eye disorder—Mesalazine—Crohn's disease	0.000938	0.00218	CcSEcCtD
Quetiapine—Tinnitus—Mesalazine—Crohn's disease	0.000936	0.00217	CcSEcCtD
Quetiapine—Cardiac disorder—Mesalazine—Crohn's disease	0.000931	0.00216	CcSEcCtD
Quetiapine—Hyperkinesia—Prednisone—Crohn's disease	0.000922	0.00214	CcSEcCtD
Quetiapine—Angiopathy—Mesalazine—Crohn's disease	0.000911	0.00212	CcSEcCtD
Quetiapine—Euphoric mood—Prednisone—Crohn's disease	0.000909	0.00211	CcSEcCtD
Quetiapine—Immune system disorder—Mesalazine—Crohn's disease	0.000907	0.00211	CcSEcCtD
Quetiapine—Mediastinal disorder—Mesalazine—Crohn's disease	0.000904	0.0021	CcSEcCtD
Quetiapine—Chills—Mesalazine—Crohn's disease	0.000901	0.00209	CcSEcCtD
Quetiapine—Diarrhoea—Mercaptopurine—Crohn's disease	0.000899	0.00209	CcSEcCtD
Quetiapine—ABCB1—epithelium—Crohn's disease	0.000894	0.00349	CbGeAlD
Quetiapine—Ill-defined disorder—Azathioprine—Crohn's disease	0.00089	0.00207	CcSEcCtD
Quetiapine—Thrombophlebitis—Prednisone—Crohn's disease	0.000887	0.00206	CcSEcCtD
Quetiapine—Anaemia—Azathioprine—Crohn's disease	0.000886	0.00206	CcSEcCtD
Quetiapine—Diabetes mellitus—Prednisone—Crohn's disease	0.000882	0.00205	CcSEcCtD
Quetiapine—Mental disorder—Mesalazine—Crohn's disease	0.000879	0.00204	CcSEcCtD
Quetiapine—ADRA2C—lymph node—Crohn's disease	0.000874	0.00341	CbGeAlD
Quetiapine—Malaise—Azathioprine—Crohn's disease	0.000865	0.00201	CcSEcCtD
Quetiapine—Flatulence—Mesalazine—Crohn's disease	0.000861	0.002	CcSEcCtD
Quetiapine—Leukopenia—Azathioprine—Crohn's disease	0.000859	0.00199	CcSEcCtD
Quetiapine—Tension—Mesalazine—Crohn's disease	0.000857	0.00199	CcSEcCtD
Quetiapine—Dysgeusia—Mesalazine—Crohn's disease	0.000856	0.00199	CcSEcCtD
Quetiapine—Nervousness—Mesalazine—Crohn's disease	0.000849	0.00197	CcSEcCtD
Quetiapine—Cardiac failure congestive—Prednisone—Crohn's disease	0.000846	0.00197	CcSEcCtD
Quetiapine—Back pain—Mesalazine—Crohn's disease	0.000845	0.00196	CcSEcCtD
Quetiapine—Muscle spasms—Mesalazine—Crohn's disease	0.00084	0.00195	CcSEcCtD
Quetiapine—Vomiting—Mercaptopurine—Crohn's disease	0.000835	0.00194	CcSEcCtD
Quetiapine—Injury—Prednisone—Crohn's disease	0.000835	0.00194	CcSEcCtD
Quetiapine—Rash—Mercaptopurine—Crohn's disease	0.000828	0.00192	CcSEcCtD
Quetiapine—Dermatitis—Mercaptopurine—Crohn's disease	0.000828	0.00192	CcSEcCtD
Quetiapine—Vision blurred—Mesalazine—Crohn's disease	0.000823	0.00191	CcSEcCtD
Quetiapine—Tremor—Mesalazine—Crohn's disease	0.000819	0.0019	CcSEcCtD
Quetiapine—Increased appetite—Prednisone—Crohn's disease	0.000817	0.0019	CcSEcCtD
Quetiapine—Amnesia—Prednisone—Crohn's disease	0.000817	0.0019	CcSEcCtD
Quetiapine—Arthralgia—Azathioprine—Crohn's disease	0.000817	0.0019	CcSEcCtD
Quetiapine—Myalgia—Azathioprine—Crohn's disease	0.000817	0.0019	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000811	0.00188	CcSEcCtD
Quetiapine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000811	0.00188	CcSEcCtD
Quetiapine—Anaemia—Mesalazine—Crohn's disease	0.000807	0.00188	CcSEcCtD
Quetiapine—Discomfort—Azathioprine—Crohn's disease	0.000807	0.00187	CcSEcCtD
Quetiapine—Angioedema—Mesalazine—Crohn's disease	0.000798	0.00185	CcSEcCtD
Quetiapine—Malaise—Mesalazine—Crohn's disease	0.000788	0.00183	CcSEcCtD
Quetiapine—Vertigo—Mesalazine—Crohn's disease	0.000785	0.00182	CcSEcCtD
Quetiapine—Syncope—Mesalazine—Crohn's disease	0.000783	0.00182	CcSEcCtD
Quetiapine—Lethargy—Prednisone—Crohn's disease	0.000783	0.00182	CcSEcCtD
Quetiapine—Leukopenia—Mesalazine—Crohn's disease	0.000782	0.00182	CcSEcCtD
Quetiapine—Nausea—Mercaptopurine—Crohn's disease	0.00078	0.00181	CcSEcCtD
Quetiapine—Infection—Azathioprine—Crohn's disease	0.000778	0.00181	CcSEcCtD
Quetiapine—ABCB1—mammalian vulva—Crohn's disease	0.000776	0.00303	CbGeAlD
Quetiapine—Palpitations—Mesalazine—Crohn's disease	0.000772	0.00179	CcSEcCtD
Quetiapine—Loss of consciousness—Mesalazine—Crohn's disease	0.000768	0.00178	CcSEcCtD
Quetiapine—Osteoarthritis—Prednisone—Crohn's disease	0.000768	0.00178	CcSEcCtD
Quetiapine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000766	0.00178	CcSEcCtD
Quetiapine—Cough—Mesalazine—Crohn's disease	0.000762	0.00177	CcSEcCtD
Quetiapine—Skin disorder—Azathioprine—Crohn's disease	0.00076	0.00177	CcSEcCtD
Quetiapine—Affect lability—Prednisone—Crohn's disease	0.000755	0.00176	CcSEcCtD
Quetiapine—Hypertension—Mesalazine—Crohn's disease	0.000754	0.00175	CcSEcCtD
Quetiapine—Psychotic disorder—Prednisone—Crohn's disease	0.00075	0.00174	CcSEcCtD
Quetiapine—Myalgia—Mesalazine—Crohn's disease	0.000744	0.00173	CcSEcCtD
Quetiapine—Arthralgia—Mesalazine—Crohn's disease	0.000744	0.00173	CcSEcCtD
Quetiapine—Chest pain—Mesalazine—Crohn's disease	0.000744	0.00173	CcSEcCtD
Quetiapine—Anxiety—Mesalazine—Crohn's disease	0.000741	0.00172	CcSEcCtD
Quetiapine—Face oedema—Prednisone—Crohn's disease	0.000741	0.00172	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000739	0.00172	CcSEcCtD
Quetiapine—Discomfort—Mesalazine—Crohn's disease	0.000735	0.00171	CcSEcCtD
Quetiapine—Irritability—Prednisone—Crohn's disease	0.000733	0.0017	CcSEcCtD
Quetiapine—Hypotension—Azathioprine—Crohn's disease	0.000731	0.0017	CcSEcCtD
Quetiapine—Cardiac arrest—Prednisone—Crohn's disease	0.00073	0.0017	CcSEcCtD
Quetiapine—Dry mouth—Mesalazine—Crohn's disease	0.000727	0.00169	CcSEcCtD
Quetiapine—Mood swings—Prednisone—Crohn's disease	0.000727	0.00169	CcSEcCtD
Quetiapine—Confusional state—Mesalazine—Crohn's disease	0.000719	0.00167	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000713	0.00166	CcSEcCtD
Quetiapine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000713	0.00166	CcSEcCtD
Quetiapine—HRH1—lymph node—Crohn's disease	0.00071	0.00277	CbGeAlD
Quetiapine—Infection—Mesalazine—Crohn's disease	0.000708	0.00165	CcSEcCtD
Quetiapine—Dry skin—Prednisone—Crohn's disease	0.000704	0.00163	CcSEcCtD
Quetiapine—Shock—Mesalazine—Crohn's disease	0.000701	0.00163	CcSEcCtD
Quetiapine—Nervous system disorder—Mesalazine—Crohn's disease	0.000699	0.00162	CcSEcCtD
Quetiapine—Hypokalaemia—Prednisone—Crohn's disease	0.000699	0.00162	CcSEcCtD
Quetiapine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000698	0.00162	CcSEcCtD
Quetiapine—ADRA2A—lymph node—Crohn's disease	0.000697	0.00272	CbGeAlD
Quetiapine—Tachycardia—Mesalazine—Crohn's disease	0.000696	0.00162	CcSEcCtD
Quetiapine—Skin disorder—Mesalazine—Crohn's disease	0.000693	0.00161	CcSEcCtD
Quetiapine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000689	0.0016	CcSEcCtD
Quetiapine—ABCB1—lymphoid tissue—Crohn's disease	0.000689	0.00269	CbGeAlD
Quetiapine—ABCB1—digestive system—Crohn's disease	0.00068	0.00266	CbGeAlD
Quetiapine—Anorexia—Mesalazine—Crohn's disease	0.00068	0.00158	CcSEcCtD
Quetiapine—Muscular weakness—Prednisone—Crohn's disease	0.000677	0.00157	CcSEcCtD
Quetiapine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000677	0.00157	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000676	0.00157	CcSEcCtD
Quetiapine—Abdominal distension—Prednisone—Crohn's disease	0.000668	0.00155	CcSEcCtD
Quetiapine—Hypotension—Mesalazine—Crohn's disease	0.000666	0.00155	CcSEcCtD
Quetiapine—Pancreatitis—Prednisone—Crohn's disease	0.00065	0.00151	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00065	0.00151	CcSEcCtD
Quetiapine—Feeling abnormal—Azathioprine—Crohn's disease	0.000645	0.0015	CcSEcCtD
Quetiapine—Insomnia—Mesalazine—Crohn's disease	0.000645	0.0015	CcSEcCtD
Quetiapine—Paraesthesia—Mesalazine—Crohn's disease	0.00064	0.00149	CcSEcCtD
Quetiapine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00064	0.00149	CcSEcCtD
Quetiapine—Dyspnoea—Mesalazine—Crohn's disease	0.000636	0.00148	CcSEcCtD
Quetiapine—Somnolence—Mesalazine—Crohn's disease	0.000634	0.00147	CcSEcCtD
Quetiapine—Dyspepsia—Mesalazine—Crohn's disease	0.000628	0.00146	CcSEcCtD
Quetiapine—Neutropenia—Prednisone—Crohn's disease	0.00062	0.00144	CcSEcCtD
Quetiapine—Decreased appetite—Mesalazine—Crohn's disease	0.00062	0.00144	CcSEcCtD
Quetiapine—Abdominal pain—Azathioprine—Crohn's disease	0.000619	0.00144	CcSEcCtD
Quetiapine—Body temperature increased—Azathioprine—Crohn's disease	0.000619	0.00144	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000616	0.00143	CcSEcCtD
Quetiapine—Fatigue—Mesalazine—Crohn's disease	0.000615	0.00143	CcSEcCtD
Quetiapine—Erectile dysfunction—Prednisone—Crohn's disease	0.000611	0.00142	CcSEcCtD
Quetiapine—Constipation—Mesalazine—Crohn's disease	0.00061	0.00142	CcSEcCtD
Quetiapine—Pain—Mesalazine—Crohn's disease	0.00061	0.00142	CcSEcCtD
Quetiapine—Weight increased—Prednisone—Crohn's disease	0.000604	0.0014	CcSEcCtD
Quetiapine—Weight decreased—Prednisone—Crohn's disease	0.0006	0.00139	CcSEcCtD
Quetiapine—Hyperglycaemia—Prednisone—Crohn's disease	0.000598	0.00139	CcSEcCtD
Quetiapine—Depression—Prednisone—Crohn's disease	0.00059	0.00137	CcSEcCtD
Quetiapine—Feeling abnormal—Mesalazine—Crohn's disease	0.000588	0.00136	CcSEcCtD
Quetiapine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000583	0.00135	CcSEcCtD
Quetiapine—Hypersensitivity—Azathioprine—Crohn's disease	0.000577	0.00134	CcSEcCtD
Quetiapine—Abdominal pain—Mesalazine—Crohn's disease	0.000564	0.00131	CcSEcCtD
Quetiapine—Body temperature increased—Mesalazine—Crohn's disease	0.000564	0.00131	CcSEcCtD
Quetiapine—Bradycardia—Prednisone—Crohn's disease	0.000541	0.00126	CcSEcCtD
Quetiapine—Diarrhoea—Azathioprine—Crohn's disease	0.000536	0.00124	CcSEcCtD
Quetiapine—Haemoglobin—Prednisone—Crohn's disease	0.000534	0.00124	CcSEcCtD
Quetiapine—Haemorrhage—Prednisone—Crohn's disease	0.000531	0.00123	CcSEcCtD
Quetiapine—Hallucination—Prednisone—Crohn's disease	0.000528	0.00123	CcSEcCtD
Quetiapine—Hypersensitivity—Mesalazine—Crohn's disease	0.000525	0.00122	CcSEcCtD
Quetiapine—Connective tissue disorder—Prednisone—Crohn's disease	0.000522	0.00121	CcSEcCtD
Quetiapine—Dizziness—Azathioprine—Crohn's disease	0.000518	0.0012	CcSEcCtD
Quetiapine—Asthenia—Mesalazine—Crohn's disease	0.000512	0.00119	CcSEcCtD
Quetiapine—Pruritus—Mesalazine—Crohn's disease	0.000504	0.00117	CcSEcCtD
Quetiapine—Vomiting—Azathioprine—Crohn's disease	0.000498	0.00116	CcSEcCtD
Quetiapine—Eye disorder—Prednisone—Crohn's disease	0.000496	0.00115	CcSEcCtD
Quetiapine—Rash—Azathioprine—Crohn's disease	0.000494	0.00115	CcSEcCtD
Quetiapine—Dermatitis—Azathioprine—Crohn's disease	0.000493	0.00115	CcSEcCtD
Quetiapine—Headache—Azathioprine—Crohn's disease	0.00049	0.00114	CcSEcCtD
Quetiapine—Diarrhoea—Mesalazine—Crohn's disease	0.000488	0.00113	CcSEcCtD
Quetiapine—Angiopathy—Prednisone—Crohn's disease	0.000482	0.00112	CcSEcCtD
Quetiapine—Immune system disorder—Prednisone—Crohn's disease	0.00048	0.00111	CcSEcCtD
Quetiapine—Dizziness—Mesalazine—Crohn's disease	0.000472	0.0011	CcSEcCtD
Quetiapine—Mental disorder—Prednisone—Crohn's disease	0.000465	0.00108	CcSEcCtD
Quetiapine—Nausea—Azathioprine—Crohn's disease	0.000465	0.00108	CcSEcCtD
Quetiapine—Malnutrition—Prednisone—Crohn's disease	0.000462	0.00107	CcSEcCtD
Quetiapine—Vomiting—Mesalazine—Crohn's disease	0.000453	0.00105	CcSEcCtD
Quetiapine—Rash—Mesalazine—Crohn's disease	0.00045	0.00104	CcSEcCtD
Quetiapine—Dermatitis—Mesalazine—Crohn's disease	0.000449	0.00104	CcSEcCtD
Quetiapine—Headache—Mesalazine—Crohn's disease	0.000447	0.00104	CcSEcCtD
Quetiapine—Vision blurred—Prednisone—Crohn's disease	0.000436	0.00101	CcSEcCtD
Quetiapine—Ill-defined disorder—Prednisone—Crohn's disease	0.000429	0.000996	CcSEcCtD
Quetiapine—Anaemia—Prednisone—Crohn's disease	0.000427	0.000993	CcSEcCtD
Quetiapine—Agitation—Prednisone—Crohn's disease	0.000425	0.000987	CcSEcCtD
Quetiapine—Nausea—Mesalazine—Crohn's disease	0.000424	0.000984	CcSEcCtD
Quetiapine—Angioedema—Prednisone—Crohn's disease	0.000422	0.000981	CcSEcCtD
Quetiapine—Malaise—Prednisone—Crohn's disease	0.000417	0.000968	CcSEcCtD
Quetiapine—Vertigo—Prednisone—Crohn's disease	0.000415	0.000965	CcSEcCtD
Quetiapine—Syncope—Prednisone—Crohn's disease	0.000415	0.000963	CcSEcCtD
Quetiapine—Loss of consciousness—Prednisone—Crohn's disease	0.000406	0.000944	CcSEcCtD
Quetiapine—Convulsion—Prednisone—Crohn's disease	0.0004	0.00093	CcSEcCtD
Quetiapine—Hypertension—Prednisone—Crohn's disease	0.000399	0.000927	CcSEcCtD
Quetiapine—Arthralgia—Prednisone—Crohn's disease	0.000394	0.000914	CcSEcCtD
Quetiapine—Myalgia—Prednisone—Crohn's disease	0.000394	0.000914	CcSEcCtD
Quetiapine—Anxiety—Prednisone—Crohn's disease	0.000392	0.000911	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000391	0.000908	CcSEcCtD
Quetiapine—Discomfort—Prednisone—Crohn's disease	0.000389	0.000903	CcSEcCtD
Quetiapine—ABCB1—lymph node—Crohn's disease	0.000389	0.00152	CbGeAlD
Quetiapine—Anaphylactic shock—Prednisone—Crohn's disease	0.000377	0.000876	CcSEcCtD
Quetiapine—Infection—Prednisone—Crohn's disease	0.000375	0.000871	CcSEcCtD
Quetiapine—Shock—Prednisone—Crohn's disease	0.000371	0.000862	CcSEcCtD
Quetiapine—Nervous system disorder—Prednisone—Crohn's disease	0.00037	0.000859	CcSEcCtD
Quetiapine—Tachycardia—Prednisone—Crohn's disease	0.000368	0.000855	CcSEcCtD
Quetiapine—Skin disorder—Prednisone—Crohn's disease	0.000366	0.000851	CcSEcCtD
Quetiapine—Hyperhidrosis—Prednisone—Crohn's disease	0.000365	0.000847	CcSEcCtD
Quetiapine—Anorexia—Prednisone—Crohn's disease	0.00036	0.000835	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000344	0.000798	CcSEcCtD
Quetiapine—Insomnia—Prednisone—Crohn's disease	0.000341	0.000793	CcSEcCtD
Quetiapine—Paraesthesia—Prednisone—Crohn's disease	0.000339	0.000787	CcSEcCtD
Quetiapine—Dyspepsia—Prednisone—Crohn's disease	0.000332	0.000771	CcSEcCtD
Quetiapine—Decreased appetite—Prednisone—Crohn's disease	0.000328	0.000762	CcSEcCtD
Quetiapine—Fatigue—Prednisone—Crohn's disease	0.000325	0.000756	CcSEcCtD
Quetiapine—Constipation—Prednisone—Crohn's disease	0.000323	0.000749	CcSEcCtD
Quetiapine—Feeling abnormal—Prednisone—Crohn's disease	0.000311	0.000722	CcSEcCtD
Quetiapine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000308	0.000717	CcSEcCtD
Quetiapine—Body temperature increased—Prednisone—Crohn's disease	0.000298	0.000693	CcSEcCtD
Quetiapine—Abdominal pain—Prednisone—Crohn's disease	0.000298	0.000693	CcSEcCtD
Quetiapine—Hypersensitivity—Prednisone—Crohn's disease	0.000278	0.000646	CcSEcCtD
Quetiapine—Asthenia—Prednisone—Crohn's disease	0.000271	0.000629	CcSEcCtD
Quetiapine—Pruritus—Prednisone—Crohn's disease	0.000267	0.00062	CcSEcCtD
Quetiapine—Diarrhoea—Prednisone—Crohn's disease	0.000258	0.0006	CcSEcCtD
Quetiapine—Dizziness—Prednisone—Crohn's disease	0.000249	0.00058	CcSEcCtD
Quetiapine—Vomiting—Prednisone—Crohn's disease	0.00024	0.000557	CcSEcCtD
Quetiapine—Rash—Prednisone—Crohn's disease	0.000238	0.000553	CcSEcCtD
Quetiapine—Dermatitis—Prednisone—Crohn's disease	0.000238	0.000552	CcSEcCtD
Quetiapine—Headache—Prednisone—Crohn's disease	0.000236	0.000549	CcSEcCtD
Quetiapine—Nausea—Prednisone—Crohn's disease	0.000224	0.000521	CcSEcCtD
Quetiapine—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	2.82e-05	9e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	2.82e-05	9e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SOCS1—Crohn's disease	2.81e-05	8.98e-05	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	2.79e-05	8.91e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	2.78e-05	8.87e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	2.78e-05	8.86e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	2.77e-05	8.85e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.77e-05	8.84e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	2.77e-05	8.84e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	2.77e-05	8.83e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	2.77e-05	8.83e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SOCS1—Crohn's disease	2.76e-05	8.82e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	2.76e-05	8.8e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	2.76e-05	8.8e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	2.75e-05	8.79e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	2.75e-05	8.79e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—CXCL8—Crohn's disease	2.75e-05	8.78e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	2.75e-05	8.78e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	2.74e-05	8.76e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	2.72e-05	8.69e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	2.72e-05	8.68e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	2.72e-05	8.67e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	2.71e-05	8.65e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—TYK2—Crohn's disease	2.68e-05	8.56e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	2.68e-05	8.55e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	2.66e-05	8.49e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	2.65e-05	8.47e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	2.65e-05	8.45e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	2.64e-05	8.43e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	2.63e-05	8.41e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—TYK2—Crohn's disease	2.63e-05	8.41e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	2.63e-05	8.38e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	2.62e-05	8.35e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling by GPCR—IL6—Crohn's disease	2.62e-05	8.35e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	2.59e-05	8.27e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	2.58e-05	8.25e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—FADS1—Crohn's disease	2.58e-05	8.23e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	2.57e-05	8.22e-05	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	2.57e-05	8.21e-05	CbGpPWpGaD
Quetiapine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.57e-05	8.2e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	2.56e-05	8.18e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—JAK2—Crohn's disease	2.56e-05	8.17e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	2.55e-05	8.14e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	2.53e-05	8.09e-05	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	2.53e-05	8.08e-05	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	2.53e-05	8.06e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	2.52e-05	8.05e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	2.52e-05	8.04e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	2.52e-05	8.04e-05	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	2.52e-05	8.04e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—JAK2—Crohn's disease	2.51e-05	8.02e-05	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	2.51e-05	8.01e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	2.5e-05	7.99e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—STAT3—Crohn's disease	2.5e-05	7.98e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	2.5e-05	7.97e-05	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	2.49e-05	7.93e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	2.48e-05	7.91e-05	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	2.48e-05	7.91e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	2.47e-05	7.89e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	2.47e-05	7.87e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	2.44e-05	7.79e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TYK2—Crohn's disease	2.44e-05	7.78e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TYK2—Crohn's disease	2.44e-05	7.77e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SMAD3—Crohn's disease	2.43e-05	7.75e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	2.42e-05	7.73e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TYK2—Crohn's disease	2.42e-05	7.72e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GPX4—Crohn's disease	2.41e-05	7.7e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	2.4e-05	7.67e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	2.39e-05	7.63e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SMAD3—Crohn's disease	2.39e-05	7.61e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	2.38e-05	7.59e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	2.37e-05	7.56e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TYK2—Crohn's disease	2.37e-05	7.56e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	2.35e-05	7.49e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	2.34e-05	7.47e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	2.34e-05	7.46e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TYK2—Crohn's disease	2.33e-05	7.44e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GCKR—Crohn's disease	2.33e-05	7.44e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—JAK2—Crohn's disease	2.33e-05	7.43e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—JAK2—Crohn's disease	2.32e-05	7.42e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—JAK2—Crohn's disease	2.31e-05	7.37e-05	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	2.3e-05	7.35e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TYK2—Crohn's disease	2.3e-05	7.34e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	2.3e-05	7.34e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	2.29e-05	7.32e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	2.29e-05	7.31e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	2.29e-05	7.3e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	2.28e-05	7.27e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—JAK2—Crohn's disease	2.26e-05	7.22e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	2.26e-05	7.2e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	2.25e-05	7.18e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL2RA—Crohn's disease	2.25e-05	7.18e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—JAK2—Crohn's disease	2.22e-05	7.1e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	2.21e-05	7.06e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—STAT3—Crohn's disease	2.21e-05	7.06e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL2RA—Crohn's disease	2.21e-05	7.05e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—ALB—Crohn's disease	2.21e-05	7.04e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TYK2—Crohn's disease	2.2e-05	7.03e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	2.2e-05	7.03e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—JAK2—Crohn's disease	2.19e-05	7e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	2.19e-05	7e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	2.17e-05	6.94e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	2.17e-05	6.94e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	2.17e-05	6.92e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—ALB—Crohn's disease	2.14e-05	6.84e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CXCL8—Crohn's disease	2.12e-05	6.78e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CXCL8—Crohn's disease	2.12e-05	6.77e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	2.11e-05	6.73e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—JAK2—Crohn's disease	2.1e-05	6.71e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TYK2—Crohn's disease	2.1e-05	6.7e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	2.09e-05	6.67e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TYK2—Crohn's disease	2.07e-05	6.61e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	2.07e-05	6.61e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	2.06e-05	6.59e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CXCL8—Crohn's disease	2.03e-05	6.48e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—IL6—Crohn's disease	2.02e-05	6.44e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—IL6—Crohn's disease	2.02e-05	6.44e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	2.01e-05	6.43e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—IL6—Crohn's disease	2e-05	6.4e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	2e-05	6.39e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—JAK2—Crohn's disease	2e-05	6.39e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—JAK2—Crohn's disease	1.98e-05	6.31e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	1.98e-05	6.31e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—IL6—Crohn's disease	1.96e-05	6.26e-05	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.93e-05	6.16e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—IL6—Crohn's disease	1.93e-05	6.16e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	1.92e-05	6.12e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—IL6—Crohn's disease	1.9e-05	6.08e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—ALB—Crohn's disease	1.9e-05	6.06e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—PTGS2—Crohn's disease	1.88e-05	5.99e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	1.87e-05	5.97e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CXCL8—Crohn's disease	1.83e-05	5.83e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—IL6—Crohn's disease	1.82e-05	5.82e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TYK2—Crohn's disease	1.81e-05	5.76e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CXCL8—Crohn's disease	1.8e-05	5.76e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	1.8e-05	5.76e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TYK2—Crohn's disease	1.8e-05	5.73e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	1.78e-05	5.69e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	1.75e-05	5.58e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—IL6—Crohn's disease	1.75e-05	5.57e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—ALB—Crohn's disease	1.74e-05	5.56e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—IL6—Crohn's disease	1.74e-05	5.55e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—JAK2—Crohn's disease	1.72e-05	5.5e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	1.72e-05	5.49e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL6—Crohn's disease	1.71e-05	5.47e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	1.71e-05	5.47e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—JAK2—Crohn's disease	1.71e-05	5.47e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—STAT3—Crohn's disease	1.71e-05	5.45e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—STAT3—Crohn's disease	1.71e-05	5.44e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—STAT3—Crohn's disease	1.69e-05	5.41e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	1.67e-05	5.32e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—PTGS2—Crohn's disease	1.66e-05	5.3e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—STAT3—Crohn's disease	1.66e-05	5.3e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	1.64e-05	5.23e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—STAT3—Crohn's disease	1.63e-05	5.21e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	1.63e-05	5.2e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—STAT3—Crohn's disease	1.61e-05	5.14e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ALB—Crohn's disease	1.6e-05	5.09e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TYK2—Crohn's disease	1.58e-05	5.06e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	1.57e-05	5.02e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	1.56e-05	4.99e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TYK2—Crohn's disease	1.56e-05	4.98e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TYK2—Crohn's disease	1.56e-05	4.97e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TYK2—Crohn's disease	1.55e-05	4.95e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	1.55e-05	4.94e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TYK2—Crohn's disease	1.55e-05	4.93e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL6—Crohn's disease	1.55e-05	4.93e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—STAT3—Crohn's disease	1.54e-05	4.92e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TYK2—Crohn's disease	1.53e-05	4.89e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	1.53e-05	4.87e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—PTGS2—Crohn's disease	1.52e-05	4.86e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	1.52e-05	4.85e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—JAK2—Crohn's disease	1.51e-05	4.83e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	1.5e-05	4.78e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL6—Crohn's disease	1.49e-05	4.77e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—JAK2—Crohn's disease	1.49e-05	4.75e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL6—Crohn's disease	1.49e-05	4.75e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—JAK2—Crohn's disease	1.48e-05	4.74e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—JAK2—Crohn's disease	1.48e-05	4.72e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—JAK2—Crohn's disease	1.47e-05	4.71e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—STAT3—Crohn's disease	1.47e-05	4.69e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—JAK2—Crohn's disease	1.46e-05	4.66e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	1.46e-05	4.65e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	1.45e-05	4.63e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—STAT3—Crohn's disease	1.45e-05	4.63e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	1.45e-05	4.62e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	1.42e-05	4.54e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	1.42e-05	4.53e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.4e-05	4.46e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL8—Crohn's disease	1.38e-05	4.4e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	1.36e-05	4.33e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL8—Crohn's disease	1.35e-05	4.32e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	1.35e-05	4.32e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	1.35e-05	4.31e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	1.35e-05	4.3e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	1.33e-05	4.26e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	1.33e-05	4.24e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—Crohn's disease	1.31e-05	4.19e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	1.31e-05	4.18e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—Crohn's disease	1.29e-05	4.12e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—Crohn's disease	1.29e-05	4.11e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—Crohn's disease	1.28e-05	4.1e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—Crohn's disease	1.28e-05	4.09e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—Crohn's disease	1.27e-05	4.05e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	1.26e-05	4.04e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—STAT3—Crohn's disease	1.26e-05	4.03e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—STAT3—Crohn's disease	1.26e-05	4.01e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	1.24e-05	3.94e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ALB—Crohn's disease	1.23e-05	3.94e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	1.22e-05	3.9e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ALB—Crohn's disease	1.2e-05	3.84e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	1.2e-05	3.84e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—Crohn's disease	1.19e-05	3.81e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—Crohn's disease	1.19e-05	3.8e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—Crohn's disease	1.18e-05	3.78e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	1.17e-05	3.75e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—Crohn's disease	1.16e-05	3.7e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—Crohn's disease	1.14e-05	3.64e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—Crohn's disease	1.13e-05	3.62e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—Crohn's disease	1.13e-05	3.59e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.11e-05	3.54e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.09e-05	3.49e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—STAT3—Crohn's disease	1.09e-05	3.48e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—STAT3—Crohn's disease	1.09e-05	3.47e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—STAT3—Crohn's disease	1.08e-05	3.46e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—PTGS2—Crohn's disease	1.08e-05	3.44e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—Crohn's disease	1.08e-05	3.44e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—STAT3—Crohn's disease	1.07e-05	3.42e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	1.07e-05	3.41e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—PTGS2—Crohn's disease	1.05e-05	3.36e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—Crohn's disease	1.03e-05	3.28e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—Crohn's disease	1.01e-05	3.23e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	1.01e-05	3.23e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	9.93e-06	3.17e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—PTGS2—Crohn's disease	9.93e-06	3.17e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—Crohn's disease	9.15e-06	2.92e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—Crohn's disease	8.83e-06	2.82e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—Crohn's disease	8.78e-06	2.8e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—Crohn's disease	8.54e-06	2.73e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	8.41e-06	2.68e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—Crohn's disease	7.75e-06	2.47e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—Crohn's disease	7.63e-06	2.43e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—Crohn's disease	7.61e-06	2.43e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—Crohn's disease	7.59e-06	2.42e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—Crohn's disease	7.56e-06	2.41e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—Crohn's disease	7.49e-06	2.39e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	7.47e-06	2.38e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—Crohn's disease	7.42e-06	2.37e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	6.94e-06	2.21e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—PTGS2—Crohn's disease	6.49e-06	2.07e-05	CbGpPWpGaD
